Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Understanding Urticaria
Urticaria, commonly known as hives, is a skin condition characterized by the sudden appearance of red, itchy welts or raised areas on the skin. These welts can vary in size and may appear on any part of the body, often changing location or shape within a few hours. Urticaria is typically triggered by allergic reactions to substances like food, medications, insect stings, or even environmental factors like heat, cold, or stress.
There are two main types of urticaria: acute and chronic. Acute urticaria lasts for less than six weeks and is usually linked to a clear allergen. Chronic urticaria, on the other hand, persists for six weeks or more and often has no identifiable cause. Treatment usually involves antihistamines to reduce itching and swelling, though more severe cases may require corticosteroids or immunosuppressants. Identifying and avoiding triggers, when possible, is key to preventing flare-ups and managing the condition effectively.
Therefore, get an overall knowledge of understanding urticaria
See More Webinars @ Hidoc Webinars
1.
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.
2.
Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.
3.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
4.
Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma
5.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
1.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
2.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
3.
Blood Donation Sustainability Through Behavioral Science
4.
Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025
5.
Essential Developments in Oncology for Healthcare Excellence
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation